Surfing the MASH Tsunami
Episodes
S3-E25.6 - Emerging Concepts In NASH: NAFLD Patient Screening, NASH Management
22 May 2022
Contributed by Lukas
Send a textThis conversation is centered on Marcelo Kugelmas's portion of Madrigal's disease-focused presentation at the Chronic Liver Disea...
S3-E25.5 - Emerging Concepts in NASH: Fatty Liver Pathophysiology, Epidemiology, Co-Morbidities
22 May 2022
Contributed by Lukas
Send a textThis conversation is centered on Mazen Noureddin's portion of Madrigal's disease-focused presentation at the Chronic Liver Diseas...
S3-E25.4 - NASH Drug Development in 2022: Will Quality of Life Data Help NASH Drugs Over the Finish Line?
22 May 2022
Contributed by Lukas
Send a textLouise Campbell starts this discussion by citing her sources of optimism about NASH drug development: (i) the high likelihood of getting a ...
S3-E25.3 - Future NASH Drug Development: More Diverse Trial Populations and More Study of Combination NASH Drugs
21 May 2022
Contributed by Lukas
Send a textThis conversation is part of a broader overview of NASH drug development in 2022, led by Stephen Harrison and Jörn Schattenberg.It starts ...
S3-E25.2 - NASH Drug Development In 2022: A Wealth of Data and a Promising NASH Pipeline
21 May 2022
Contributed by Lukas
Send a textThis conversation is part of a broader overview of NASH drug development in 2022, led by Stephen Harrison and Jörn Schattenberg.It starts ...
S3-E25.1 - NASH Drug Development in 2022: Late-Stage NASH Drugs and Their Path to Market
21 May 2022
Contributed by Lukas
Send a textThis conversation is part of a broader overview of NASH drug development in 2022, led by Stephen Harrison and Jörn Schattenberg.Stephen st...
S3-E25 - Crystal Ball Looks at Drug Development and the NASH Pipeline
19 May 2022
Contributed by Lukas
Send a textThis week, NASH Tsunami responds to listeners who have asked "Where are the episodes on drug development?" by asking Stephen Harr...
S3-E24.5 - From #INCBCN: Digital Health and Patient Empowerment: a Conversation with Dr. Marcus Ranney
15 May 2022
Contributed by Lukas
Send a textOne of the most intriguing presentations at this month's inaugural Innovations in NAFLD Care 2022 conference (#INCBCN) came from physi...
3-E24.4 - Innovations in NAFLD Care Conference: What Is the Importance of Steatosis in Metabolic Health?
15 May 2022
Contributed by Lukas
Send a textOn May 6 and 7, over 100 NAFLD stakeholders convened in Barcelona and on-line for the inaugural Innovations in NAFLD Care 2022 conference (...
S3-E24.3 - Stakeholder Diversity at the Innovations in NAFLD Care 2022 Conference: a Critical Success Factor
15 May 2022
Contributed by Lukas
Send a textOn May 6 and 7, over 100 NAFLD stakeholders convened in Barcelona and on-line for the inaugural Innovations in NAFLD Care 2022 conference (...
S3-E24.2 - Controversy at the Innovations in NAFLD Care Conference: What Does Patient Empowerment Mean in Fatty Liver Disease?
14 May 2022
Contributed by Lukas
Send a textOn May 6 and 7, over 100 NAFLD stakeholders convened in Barcelona and on-line for the inaugural Innovations in NAFLD Care 2022 conference (...
S3-E24.1 - Did the Innovations in NAFLD Care Conference Strengthen the Case for an Integrated NAFLD Care Pathway?
14 May 2022
Contributed by Lukas
Send a textOn May 6 and 7, over 100 NAFLD stakeholders convened in Barcelona and on-line for the inaugural Innovations in NAFLD Care 2022 conference (...
S3-E24 - #INCBCN (Innovations in NAFLD Care 2022) Wrap-up plus Interview with Human Edge Founder Dr. Marcus Ranney
12 May 2022
Contributed by Lukas
Send a textLast week, all three #NASHTsunami co-hosts participated in the inaugural Innovations in NAFLD Care (#INCBCN) 2022 conference in Barcelona. ...
S3-E23.5 - How NAFLD Patient Advocacy Works: Two Key Pieces
08 May 2022
Contributed by Lukas
Send a textThe entire Fatty Liver community benefits from NASH Patient Advocacy and the work of our advocates, but relatively few of us understand wha...
S3-E23.4 - How NAFLD Patient Advocacy Works: Targets and Opportunities for the Fatty Liver Community
08 May 2022
Contributed by Lukas
Send a textThe entire Fatty Liver community benefits from NASH Patient Advocacy and the work of our advocates, but relatively few of us understand wha...
S3-E23.3 - How NAFLD Patient Advocacy Works: Disease Targets and Policy Successes in The Fatty Liver Community
07 May 2022
Contributed by Lukas
Send a textThe entire Fatty Liver community benefits from NASH Patient Advocacy and the work of our advocates, but relatively few of us understand wha...
S3-E23.2 - How NAFLD Patient Advocacy Works: Targets and Opportunities for the Fatty Liver Community
07 May 2022
Contributed by Lukas
Send a textThe entire Fatty Liver community benefits from NASH Patient Advocacy and the work of our advocates, but relatively few of us understand wha...
S3-E23.1 - NAFLD Patient Advocacy: Meet the Advocates And Hear Their Stories
07 May 2022
Contributed by Lukas
Send a textThe entire Fatty Liver community benefits from NASH Patient Advocacy and the work of our advocates, but relatively few of us understand wha...
S3-E23 - So How Does NAFLD Patient Advocacy Support the Entire Fatty Liver Community?
05 May 2022
Contributed by Lukas
Send a textThe entire Fatty Liver community benefits from NASH Patient Advocates and the work of our advocates, but relatively few of us understand wh...
S3-E22.4 - Previewing the 5th Global NASH Congress: Summing Up
01 May 2022
Contributed by Lukas
Send a textThe 5th Global NASH Congress will take place in London (in person only) on May 27 and 28. Louise Campbell and scientist/entrepreneur Rachel...
S3-E22.3 - Previewing the 5th Global NASH Congress: NASH Drug Development Presentations
01 May 2022
Contributed by Lukas
Send a textThe 5th Global NASH Congress will take place in London (in person only) on May 27 and 28. Louise Campbell and scientist/entrepreneur Rachel...
S3-E22.2 - Previewing the 5th Global NASH Congress: What can We Learn About Drugs in Development From Hepatic Cell Models and Advanced Omics?
30 Apr 2022
Contributed by Lukas
Send a textThe 5th Global NASH Congress will take place in London (in person only) on May 27 and 28. Louise Campbell and scientist/entrepreneur Rachel...
S3-E22.1 - Previewing the 5th Global NASH Congress: Gut Microbiome and Nutrition are the New Frontier
30 Apr 2022
Contributed by Lukas
Send a textThe 5th Global NASH Congress will take place in London (in person only) on May 27 and 28. Louise Campbell and scientist/entrepreneur Rachel...
S3-E22 - NASH Tsunami previews the 5th Global NASH Congress
28 Apr 2022
Contributed by Lukas
Send a textThe 5th Global NASH Congress will take place in London on May 26-27. Surfing the NASH Tsunami is serving as a Media Partner for the event. ...
S3-E21.5 - NAFLD Provider education, NASH Patient Care and Digital Health
24 Apr 2022
Contributed by Lukas
Send a textThis conversation includes part of a more extended discussion that Donna Cryer had with Louise Campbell and Roger Green when she stopped by...
S3-E21.4 - Donna Cryer Discusses NCQA on NASH Quality and the New GLI "Liver Health is Public Health" campaign
24 Apr 2022
Contributed by Lukas
Send a textThis conversation includes part of a more extended discussion that Donna Cryer had with Louise Campbell and Roger Green when she stopped by...
S3-E21.3 - Digital Health and Behavioral Support apps in Future NASH Therapies
23 Apr 2022
Contributed by Lukas
Send a textThis conversation includes part of a more extended discussion that Naim Alkhouri had with Louise Campbell and Roger Green when he stopped b...
S3-E21.2 - NAFLD Incidence in All Americans and The NASH-Diabetes Link
23 Apr 2022
Contributed by Lukas
Send a textThis conversation includes part of a longer discussion that Naim Alkhouri had with Louise Campbell and Roger Green when he stopped by the v...
S3-E21.1 - Challenges in NAFLD Care Delivery: Primary Care and NASH
23 Apr 2022
Contributed by Lukas
Send a textThis conversation on NAFLD Care Delivery and NASH practices comes from Episode 20, our introductory conversation with newly designated full...
S3-E21 - Naim Alkhouri and Donna Cryer Bring News to Surfing the NASH Tsunami
21 Apr 2022
Contributed by Lukas
Send a textArizona Liver Health Institute V.P. of Academic Affairs and Fatty Liver Program Director Naim Alkhouri and Global Liver Institute Founder a...
S3-E20 - Jörn Schattenberg, Louise and Roger discuss NAFLD and SurfingNASH.com
20 Apr 2022
Contributed by Lukas
Send a textSurfingNASH.com has produced this special, single-interview episode to give listeners a chance to learn about Jörn Schattenberg in a diffe...
S3-E19.5 - NAIL-NIT: Expanding Vistas for Phase 1 Research
17 Apr 2022
Contributed by Lukas
Send a textThis conversation starts with Stephen Harrison discussing the scope of current NITs in the context of what NAIL-NIT needs to achieve. "...
S3-E19.4 - NAIL-NIT: "Morphic Resonance" and FDA Test Criteria
17 Apr 2022
Contributed by Lukas
Send a textThis conversation starts with discussing how challenging it was to develop initial FDA test criteria for evaluating NASH drugs. Many years ...
S3-E19.3 - NAIL-NIT: What Naim Alkhouri and Jörn Schattenberg Plan for Retrospective Analysis
16 Apr 2022
Contributed by Lukas
Send a textThis conversation starts with Naim Alkhouri and Jörn Schattenberg defining the wealth of data resources and hypotheses they are bringing t...
S3 - E19.2 - Beginnings And Core Principles In The Move Beyond the Biopsy
16 Apr 2022
Contributed by Lukas
Send a textIn this brief conversation, Stephen Harrison discusses the exciting goal and ambitious research plan for NAIL-NIT, after which Mazen Noured...
S3-E19.1 - Podcast News: SurfingNASH.com Is Here and a New Role for Jörn Schattenberg!
16 Apr 2022
Contributed by Lukas
Send a textThis week marks the 2nd anniversary for Surfing the NASH Tsunami! This conversation celebrates our anniversary and brings news about the fo...
3-E19 - What Can NAIL-NIT Retrospective Analysis Tell Us About NASH Clinical Trials?
14 Apr 2022
Contributed by Lukas
Send a textThis 2nd Anniversary episode focuses on what the retrospective analysis from the NAIL-NIT consortium can achieve in terms of driving the sh...
S3-E18.4 - Previewing Innovations in NAFLD Care 2022: Day Two Sessions
10 Apr 2022
Contributed by Lukas
Send a textThis week's episode and conversations preview the inaugural Innovations in NAFLD Care Workshop, premiering in Barcelona on May 6 and 7...
S3-E18.3 - Previewing Innovations in NAFLD Care 2022: SItes of Care and Organizing Patients
10 Apr 2022
Contributed by Lukas
Send a textThis week's episode and conversations preview the inaugural Innovations in NAFLD Care Workshop, premiering in Barcelona on May 6 and 7...
S3-E18.2 - Previewing Innovations in NAFLD Care 2022: NASH Epidemiology
09 Apr 2022
Contributed by Lukas
Send a textThis week's episode and conversations preview the inaugural Innovations in NAFLD Care Workshop, premiering in Barcelona on May 6 and 7...
S3-E18.1 - Why the Innovations in NAFLD Care Conference Came to Be
09 Apr 2022
Contributed by Lukas
Send a textThis week's episode and conversations preview the inaugural Innovations in NAFLD Care Workshop, premiering in Barcelona on May 6 and 7...
S3-E18 - Previewing The Innovations In NAFLD Care 2022 Conference
07 Apr 2022
Contributed by Lukas
Send a textConference founders and directors Jeffrey Lazarus and Jörn Schattenberg join Roger Green to preview the inaugural Innovations in NAFLD Car...
S3-E17.4 - What Can Single Cell Genomics Teach about Hepatic Regeneration?
03 Apr 2022
Contributed by Lukas
Send a textProfessors Scott Friedman and Neil Henderson join the Surfers (including the returning Stephen Harrison) to discuss some truly exciting adv...
S3-E17.3 - Spatial Transcriptomics and The History of Single Cell Genomics
03 Apr 2022
Contributed by Lukas
Send a textProfessors Scott Friedman and Neil Henderson join the Surfers (including the returning Stephen Harrison) to discuss some truly exciting adv...
S3-E17.2 - Future Targeted NASH Therapies and NASH Drug Development Today
02 Apr 2022
Contributed by Lukas
Send a textProfessors Scott Friedman and Neil Henderson join the Surfers (including the returning Stephen Harrison) to discuss some truly exciting adv...
S3-E17.1 - Potential Breakthrough in Anti-Fibrotic Therapies Through mRNA/CAR-T Combined Therapies
02 Apr 2022
Contributed by Lukas
Send a textProfessors Scott Friedman and Neil Henderson join the Surfers (including the returning Stephen Harrison) to discuss some truly exciting adv...
S3-E17 - New In NASH Science: CAR-T/mRNA Anti-Fibrotics and Advanced NASH omics
31 Mar 2022
Contributed by Lukas
Send a textProfessors Scott Friedman and Neil Henderson join the Surfers (including the returning Stephen Harrison) to discuss some truly exciting adv...
S3-E16.5 - Ready for "Prime Time?" - MRE and Hepatogram in NASH Clinical Practice
27 Mar 2022
Contributed by Lukas
Send a textThe conversation was originally recorded on January 27, 2022. It focuses on use of MR Elastography to diagnose, treat and monitor NASH pati...
S3-E16.4 - What a Disease Model Suggests about the NASH Diagnostic Path
27 Mar 2022
Contributed by Lukas
Send a textThis conversation starts by focusing on issues related to diagnostic testing and what we attempt to detect or prove with each test. It star...
S3-E16.3 - What a Disease Model tells Us About NASH Patient Management
27 Mar 2022
Contributed by Lukas
Send a textThis conversation explores the impact some suggestions and questions that arose at Liver Connect might have on data modeling. Roger Green s...
S3-E16.2 - What a NASH Disease Model Reveals About Treating Advanced Fibrosis
26 Mar 2022
Contributed by Lukas
Send a textThis conversation starts with Chris Estes describing the processes he and his colleagues at the Center for Disease Analysis Foundation have...
S3-E16.1 - Building a Disease Model for NASH Prevalence: Key Challenges
26 Mar 2022
Contributed by Lukas
Send a textThis conversation starts with Chris Estes describing the processes he and his colleagues at the Center for Disease Analysis Foundation have...
S3-E16 - The Prospective Role of Data Modeling in Diagnostic and Drug Development
24 Mar 2022
Contributed by Lukas
Send a textIn Episode 13, we explored ways that data modeling can inform a deeper understanding of the value of community and primary care VCTE screen...
S3-E15.4 - CLDF Liver Connect program: How Well Did It Work?
20 Mar 2022
Contributed by Lukas
Send a textLast weekend, over 400 liver disease stakeholders gathered in Scottsdale, Arizona for the 2nd Annual Liver Connect Conference, sponsored by...
S3-E15.3 - From the 2022 Liver Conference: Pediatric NAFLD and Liver Health Education
20 Mar 2022
Contributed by Lukas
Send a textLast weekend, over 400 liver disease stakeholders gathered in Scottsdale, Arizona for the 2nd Annual Liver Connect Conference, sponsored by...
S3-E15.1 - An Interview with CLDF President Zobair Younossi about Liver Connect
19 Mar 2022
Contributed by Lukas
Send a textLast weekend, over 400 liver disease stakeholders gathered in Scottsdale, Arizona for the 2nd Annual Liver Connect Conference, sponsored by...
S3-E15.2 - Discussing Health Disparities at CLDF's NASH Connect Conference
18 Mar 2022
Contributed by Lukas
Send a textLast weekend, over 400 liver disease stakeholders gathered in Scottsdale, Arizona for the 2nd Annual Liver Connect Conference, sponsored by...
S3-E15 - Discussing NAFLD and NASH at CLDF's 2nd Annual Liver Connect
17 Mar 2022
Contributed by Lukas
Send a textLast weekend, over 400 liver disease stakeholders gathered in Scottsdale, Arizona for the 2nd Annual Liver Connect Conference, sponsored by...
S3-E14.5 - Improving Ballooned Hepatocyte Analysis Through Artificial Intelligence
14 Mar 2022
Contributed by Lukas
Send a textThe episode and this conversation is sponsored by HistoIndex. This specific conversation focuses on ways and AI-assistive technologies and ...
S3-E14.4 - Ballooned Hepatocyte Analysis and Reassessing Drug Development
13 Mar 2022
Contributed by Lukas
Send a textOne major discussion at NASH-TAG this year was about the inconsistency in ballooned hepatocyte identification and how this inconsistency in...
S3-E14.3 - Systematic Flaws in Semi-Quantitative Ballooned Hepatocyte Analysis
13 Mar 2022
Contributed by Lukas
Send a textOne major discussion at NASH-TAG this year was about the inconsistency in ballooned hepatocyte identification and how this inconsistency in...
S3-E14.2 - Can We Manage Statistical Error in Ballooned Hepatocyte Analysis Better?
12 Mar 2022
Contributed by Lukas
Send a textOne major discussion at NASH-TAG this year was about the inconsistency in ballooned hepatocyte identification and how this inconsistency in...
S3-E14.1 - How Ballooned Hepatocyte Analytics Weaken NASH Clinical Trials
12 Mar 2022
Contributed by Lukas
Send a textOne major discussion at NASH-TAG this year was about the inconsistency in ballooned hepatocyte identification and how this inconsistency in...
S3-E14 - NAS Scores and the Challenge of Complex Ballooned Hepatocytes
10 Mar 2022
Contributed by Lukas
Send a textOne major discussion at NASH-TAG this year was about the inconsistency in ballooned hepatocyte identification and how this inconsistency in...
S3-E13.4 - The NICE Draft Guidance vs. The Economics of NAFLD: Not a Great Fit
06 Mar 2022
Contributed by Lukas
Send a textEpisode 13 looks at the NICE Draft Guidance Evaluating FibroScan use in Community and Primary Care settings. This conversation focuses on u...
S3-E13.3 - NICE Draft Guidance on NAFLD Screening: Long Term Issues
06 Mar 2022
Contributed by Lukas
Send a textEpisode 13 looks at the NICE Draft Guidance Evaluating FibroScan use in Community and Primary Care settings. This conversation focuses on t...
S3-E13.2 - NICE Assesses FibroScan Screening: Health Economics & NAFLD
05 Mar 2022
Contributed by Lukas
Send a textEpisode 13 looks at the NICE Draft Guidance Evaluating FibroScan use in Community and Primary Care settings. This conversation focuses on s...
S3-E13.1 - NICE Assesses FibroScan Community Screening: Analytic Tensions
05 Mar 2022
Contributed by Lukas
Send a textEpisode 13 looks at the NICE Draft Guidance Evaluating FibroScan use in Community and Primary Care settings. This conversation focuses on t...
S3-E13 - Community Screening for NAFLD: What Must Advocates Prove?
03 Mar 2022
Contributed by Lukas
Send a textThe UK's National Institute for Health and Care Excellence (NICE) issues health economics-based decisions on whether therapies and dia...
S3 E12.4 - What Will Improve NASH Care For Black Americans Most and Fastest
27 Feb 2022
Contributed by Lukas
Send a textThroughout this podcast, panelists uncovered a large set of actions that might improve NASH care for those Black Americans who have the dis...
S3-E12.3 - The Need: Enrich Black America's NASH Clinical Trials Share
27 Feb 2022
Contributed by Lukas
Send a textWith so many major clinical trials for Fatty Liver drugs recruiting over the next couple of years, we have an opportunity to study effects ...
S3-E12.2 - Why NASH Might Be Different For Black Americans: SDOH, Omics
26 Feb 2022
Contributed by Lukas
Send a textFactors that make treating NASH and NAFLD a unique challenge for non-Hispanic Black Americans range from Social Determinants of Health (SDO...
S3-E12.1 - NASH Care for Non-Hispanic Black Americans: The Issues and Why They Matter
26 Feb 2022
Contributed by Lukas
Send a textHow do you discuss a disease with no history during Black History month? Surfing the NASH Tsunami asked, "What challenges exist for no...
S3-E12 - Non-Hispanic Black Americans, SDOH and NASH
24 Feb 2022
Contributed by Lukas
Send a textIn recognition of Black History Month, SurfingNASH looks at how the impact of NASH on non-Hispanic Black Americans differs from other group...
S3-E11.4 - NAIL-NIT: Retrospective Analysis, Then Prospective Studies
20 Feb 2022
Contributed by Lukas
Send a textThis wrap-up conversation of our NAIL-NIT episode provides greater detail on NAIL-NIT's research plan. The plan itself includes two el...
S3-E11.3 - NAIL-NIT and the Challenges of the NAS Score
20 Feb 2022
Contributed by Lukas
Send a textThe conversation looks at how the NAIL-NIT program design improves on the quality of insight provided by the NAS score, both in terms of dr...
S3-E11.2 - NAIL-NIT and the Challenges of Histopathology
19 Feb 2022
Contributed by Lukas
Send a textNAIL-NIT is both a response to the challenges of histopathology and an effort to create a different vision of testing liver patients.This e...
S3-E11.1 - NAIL-NIT: The Thinking Behind a New NAFLD Consortium
19 Feb 2022
Contributed by Lukas
Send a textNAIL-NIT is a new NAFLD consortium dedicated to exploring the direct relationship between non-invasive testing (NITs) and outcomes in Fatty...
S3-E11 - NAIL-NIT and the Path from Non-Invasive Testing To Outcomes
17 Feb 2022
Contributed by Lukas
Send a textCo-director Mazen Noureddin and Steering Committee members Amy Articolo of Novo Nordisk and Senthil Sundaram of Terns Pharmaceuticals join ...
S3-E10.4 - Value of Screening for NAFLD as NASH Prevalence Grows
13 Feb 2022
Contributed by Lukas
Send a textEpisode 10 dives into recent NAFLD and NASH Prevalence studies in the US, UK and Germany and explores what this can tell us about who to sc...
S3-E10.3 - Value of Early NASH Diagnosis as NAFLD Prevalence Grows
13 Feb 2022
Contributed by Lukas
Send a textEpisode 10 dives into recent NAFLD and NASH Prevalence studies in the US, UK and Germany and explores what this can tell us about who to sc...
S3-E10.2 - What Does the SUNN Study Say About NASH Prevalence?
12 Feb 2022
Contributed by Lukas
Send a textEpisode 10 dives into recent NAFLD and NASH Prevalence studies in the US, UK and Germany and explores what this can tell us about who to sc...
S3-E10.1 - NAFLD and NASH Prevalence and Advanced Liver Fibrosis in Germany
12 Feb 2022
Contributed by Lukas
Send a textEpisode 10 dives into recent NAFLD and NASH Prevalence studies in the US, UK and Germany and explores what this can tell us about who to sc...
S3-E10 - Screening and Treatment Pathways in a World with High NAFLD Prevalence
10 Feb 2022
Contributed by Lukas
Send a textThis episode looks at four different sources of data estimating NASH and NAFLD prevalence in population subgroups the US, UK and Germany. A...
S3-E9.4 - NASH Patient Care: The Value of Patient Education
06 Feb 2022
Contributed by Lukas
Send a textThis conversation explores the need for and value of patient education in the NASH Patient Care process. It starts with almost a tangential...
S3-E9.3 - NASH Patient Education: Liver Nurses' Roles
06 Feb 2022
Contributed by Lukas
Send a textThis conversation explores the different challenges that liver nurses and advanced practitioners face when providing NASH patient education...
S3-E9.2 - NASH Patient Support: Liver Nursing Challenges
05 Feb 2022
Contributed by Lukas
Send a textThis conversation explores the different challenges that liver nurses and advanced practitioners face when providing NASH patient support.I...
S3-E9.1 - NASH Patient Support: Meet Today's Liver Nurses
05 Feb 2022
Contributed by Lukas
Send a textEpisode 9 asks the question, "Are We Taking Full Advantage of the Skills and Knowledge that Liver Nurses and Advanced Nurse Practition...
S3-E9 - Are We Taking Full Advantage of the Skills and Knowledge that Liver Nurses and Advanced Nurse Practitioners Bring To NASH Education and Patient Care?
03 Feb 2022
Contributed by Lukas
Send a textLouise Campbell convenes liver nursing and nurse educator experts Kathryn Jack, Michele Clayton, Pam O'Donoghue and Patrizia Kunzler...
S3-E8.4 - SurfingNASH Discusses The Innovations In NAFLD Care 2022 Series With Jeff Lazarus And Jörn Schattenberg: Agenda Concepts
30 Jan 2022
Contributed by Lukas
Send a textThe Innovations in NAFLD Care 2022 Series includes a recent webinar and a hybrid meeting planned for Barcelona in May. This new event is a ...
S3-E8.3 - SurfingNASH Discusses The Innovations In NAFLD Care 2022 Series With Jeff Lazarus And Jörn Schattenberg: Structural Healthcare Issues
30 Jan 2022
Contributed by Lukas
Send a textThe Innovations in NAFLD Care 2022 Series includes a recent webinar and a hybrid meeting planned for Barcelona in May. This new event is a ...
S3-E8.2 - SurfingNASH discusses the Innovations in NAFLD Care 2022 Series with Jeff Lazarus and Jörn Schattenberg: Program Scope and Key Elements
29 Jan 2022
Contributed by Lukas
Send a textThe Innovations in NAFLD Care 2022 Series includes a recent webinar and a hybrid meeting planned for Barcelona in May. This new event is a ...
S3 E8.1 - SurfingNASH Discusses The Innovations In NAFLD Care 2022 Series With Jeff Lazarus And Jörn Schattenberg: Program Objectives
29 Jan 2022
Contributed by Lukas
Send a textThe Innovations in NAFLD Care 2022 Series includes a recent webinar and a hybrid meeting planned for Barcelona in May. This new event is a ...
S3-E8 - The "Innovations in NAFLD Care 2022" Series: Promoting the NAFLD Public Health Agenda
27 Jan 2022
Contributed by Lukas
Send a textProgram co-chairs Jeff Lazarus and Jörn Schattenberg join the Surfers to discuss their "Innovations in NAFLD Care 2022" series a...
S3-E6 - Themes From NASH-TAG 2022: Insights on Combination Therapies
22 Jan 2022
Contributed by Lukas
Send a textRoger Green assemblies audio clips from Surfing the NASH Tsunami's coverage of NASH-TAG 2022 to reveal an evolving view of the role co...
S3-E5 - NASH-TAG 2022 bonus: A conversation with Donna Cryer and Scott Friedman
21 Jan 2022
Contributed by Lukas
Send a textGlobal Liver Institute Founder and CEO Donna Cryer and Key Opinion Leader Professor Scott Friedman joined Roger Green at NASH-TAG 2022 for ...
S3-E4.4 - NASH-TAG 2022 Wrap-up: Improving Cost Efficiency of NASH Trials By Reducing Screen Fail Rates
16 Jan 2022
Contributed by Lukas
Send a textLast weekend's NASH-TAG 2022 was the best attended event in the conference's six-year history, and probably the one that will hav...
S3-E4.3 - NASH-TAG 2022 Wrap-up: NITs from The FDA and Patients' Perspectives
16 Jan 2022
Contributed by Lukas
Send a textLast weekend's NASH-TAG 2022 was the best attended event in the conference's six-year history, and probably the one that will hav...
S3-E4.2 - NASH-TAG 2022 Wrap-up: The Fireside Chat and the Changing Paradigm For NASH Diagnostics
15 Jan 2022
Contributed by Lukas
Send a textLast weekend's NASH-TAG 2022 was the best attended event in the conference's six-year history, and probably the one that will hav...
S3-E4.1 - NASH-TAG 2022 Wrap-up: High Impact presentations
15 Jan 2022
Contributed by Lukas
Send a textLast weekend's NASH-TAG 2022 was the best attended event in the conference's six-year history, and probably the one that will hav...